Compare MNDO & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNDO | HIND |
|---|---|---|
| Founded | 1995 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2M | 28.0M |
| IPO Year | 2000 | 2016 |
| Metric | MNDO | HIND |
|---|---|---|
| Price | $1.16 | $2.45 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 26.1K | N/A |
| Earning Date | 03-03-2026 | N/A |
| Dividend Yield | ★ 19.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $19,770,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $8.14 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.98 | N/A |
| 52 Week High | $2.13 | N/A |
| Indicator | MNDO | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 40.69 | 44.27 |
| Support Level | $1.19 | $1.75 |
| Resistance Level | $1.25 | $2.93 |
| Average True Range (ATR) | 0.05 | 0.43 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 0.09 | 37.52 |
MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.